[Do advances in molecular biology change indications for adjuvant chemotherapy in colorectal cancer?]
Gastroenterol Clin Biol
.
2001 Aug-Sep;25(8-9):837-8.
[Article in French]
Authors
I Roque
1
,
P Michel
Affiliation
1
Hôpital Charles-Nicolle, CHU, Rouen, France.
PMID:
11697319
No abstract available
MeSH terms
Adenocarcinoma / drug therapy*
Antineoplastic Agents / therapeutic use
Chemotherapy, Adjuvant*
Colonic Neoplasms / drug therapy*
Humans
Microsatellite Repeats*
Prognosis
Substances
Antineoplastic Agents